首页 › 基金 › LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA › IDXX

LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA 对 IDXX 的持仓历史

IDEXX LABS INC · 医疗保健

LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA 在 Q3 2026 的 13F 申报中披露持有 IDXX(IDEXX LABS INC)114,834 股,市值约 US$60.0M,约占其申报组合的 0.55%,在其申报持仓中市值排名第 42 位。 LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA 最近 13 个申报季度中有 13 个季度披露了 IDXX 持仓,最早可追溯至 Q3 2023。

最新持仓 (Q3 2026)114.83K 股
申报持仓市值$59.97M
组合权重0.55%
首次申报Q3 2023
最近变动减持
更新于2026-11-13

最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR

LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA 对 IDXX 的持仓演变

LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA 于 Q3 2023 首次披露 IDXX 持仓:150,364 股(约 US$63.1M)。 该持仓在 Q4 2025 达到峰值 124,045 股,市值约 US$86.2M。 在 13 次申报中,LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA 0 次增持、11 次减持、1 次保持不变。 最近一期申报(Q3 2026)显示持股 114,834 股、市值约 US$60.0M,环比减持 -2,361 股。。

逐季持仓明细

季度股数金额变化
Q3 2023 150.36K $63.07M 新进
Q4 2023 141.80K $73.04M 减持
Q1 2024 140.28K $67.27M 减持
Q2 2024 139.21K $69.54M 减持
Q3 2024 134.83K $60.98M 减持
Q4 2024 134.46K $57.48M 持有
Q1 2025 133.78K $57.07M 减持
Q2 2025 131.68K $70.63M 减持
Q3 2025 127.11K $81.17M 减持
Q4 2025 124.05K $86.18M 减持
Q1 2026 122.30K $68.86M 减持
Q2 2026 117.19K $61.70M 减持
Q3 2026 114.83K $59.97M 减持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 IDXX 与 13F 数据

IDXX(IDEXX LABS INC)属于医疗保健行业。我们追踪的基金中还有 28 只申报持有 IDXX,申报仓位最大的包括:Baron 基金 (US$1.04B), BAMCO INC /NY/ (US$1.04B), Fundsmith LLP (US$536.9M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 IDXX 的基金

查看 IDXX 的全部基金持有人 →

常见问题

How long has LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA held IDXX?

LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA has disclosed IDXX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA's current position in IDXX?

As of Q3 2026, LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA holds 114.83K shares of IDXX (IDEXX LABS INC), valued at $59.97M, representing 0.55% of its reported portfolio and ranking #42.

Has LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA been buying or selling IDXX?

In the latest 13F filing (Q3 2026), LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA reduced its position in IDXX. The position peaked in Q4 2025 at 124.05K shares.

Which other funds hold IDXX?

Other major institutional holders of IDXX include Baron 基金, BAMCO INC /NY/, Fundsmith LLP, among 28 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.